Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Startups & Unicorns companies in Carbonic anhydrase inhibitor
by Most News Heat in the world in 2022

The Carbonic anhydrase inhibitor top 10 is Discovery PatSnap’ annual ranking of the top 10 Most News Heat Carbonic anhydrase inhibitor Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Carbonic anhydrase inhibitors are a class of pharmaceuticals that suppress the activity of carbonic anhydrase. Their clinical use has been established as anti-glaucoma agents, diuretics, antiepileptics, in the management of mountain sickness, gastric and duodenal ulcers, idiopathic intracranial hypertension, neurological disorders, or osteoporosis.
#
Company Name
Region
Tech Topics
Total
1
EVS Glaucoma Therapeutics LLC
Glaucoma medication,Drug,Glaucoma,
...[+2]
news: 5
2
RNA,Biology,Health care,
...[+2]
news: 3
3
Africa co
Self-organizing network,GSM,News media,
...[+1]
news: 3
4
Visual impairment,Health care,Pharmacy and Therapeutics,
...[+2]
news: 2
5
The Business Research Co.
United Kingdom
Business Research,Market research,Database
news: 1
6
North
Syddanmark, Denmark
news: 1
7
Reistone Biopharma Co. Ltd.
Shandong Sheng, China
news: 1
8
Delveinsight Business Research LLP
Delhi, India
Market research,Health care
news: 1
9
AffaMed Therapeutics
news: 1
10
Drug,Eye drop,Health care,
...[+2]
news: 1
Page generation time: Apr 28 2025